TS
Terri Smith Bresenham
About Terri Smith Bresenham
Data last updated:
Terri Smith Bresenham is a Director at Narayana Hrudayalaya Limited (since 2021) and Director at Tata Medical And Diagnostics Limited (since 2021). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹5,583 Cr; the largest is Narayana Hrudayalaya Limited at ₹5,575 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Aug 2021 | 2000 | ₹5,575 Cr (FY 2025) | Active | |
| Director | 23 Mar 2021 | 2020 | ₹7.73 Cr (FY 2025) | Active |
Board colleagues of Terri Smith Bresenham
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Terri Smith Bresenham
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Terri Smith Bresenham
Terri Smith Bresenham currently holds 2 directorships: Narayana Hrudayalaya Limited (Director, since 05 Aug 2021, revenue ₹5,575 Cr (FY 2025)); Tata Medical And Diagnostics Limited (Director, since 23 Mar 2021, revenue ₹7.73 Cr (FY 2025)).
Terri Smith Bresenham was first appointed on 23 Mar 2021 as Director at Tata Medical And Diagnostics Limited.
The 2 current companies of Terri Smith Bresenham that report revenue have a combined latest revenue of ₹5,583 Cr: Narayana Hrudayalaya Limited ₹5,575 Cr (FY 2025); Tata Medical And Diagnostics Limited ₹7.73 Cr (FY 2025).
The current boards of Terri Smith Bresenham's companies include Anesh Shetty (Narayana Hrudayalaya Limited), Arunachalam Shankar (Narayana Hrudayalaya Limited), Devi Prasad Shetty (Narayana Hrudayalaya Limited), Emmanuel Rupert (Narayana Hrudayalaya Limited), Kiran Mazumdar Shaw (Narayana Hrudayalaya Limited), Nachiket Mor (Narayana Hrudayalaya Limited), among others.